The European cardiovascular medical device industry was presented on 20 May at the annual meeting of the European Association for Percutaneous Cardiovascular Interventions with the Ethica Award for its contribution to improving European patient care. Interventional cardiologists use narrow tubes, or catheters, passed through arteries or veins to reach the heart or other organs to carry out procedures and insert devices to treat disease. The award recognizes the role played by safe, innovative cardiovascular devices in addressing unmet medical needs and improving patient survival rates and quality of life.
Today, coinciding with the European Ministerial eHealth Conference in Budapest, Eucomed, the European medical technology industry association, has launched its position paper on eHealth describing the industry perspective including seven criteria that play a critical role in enabling the transformation of healthcare systems across Europe.
Patients with cardiovascular disease have an increased risk of heart failure and death. In such patients an implantable cardioverter defibrillator (ICD) can often improve survival rates. Selected patients could benefit from a combination of an ICD and cardiac resynchronisation therapy (CRT-D), thus a clinical trial was designed to determine if combined ICD – CRT-D treatment reduces the risk of mortality and heart failure (HF) events.